Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Improved oxazolidinone prodrugs reported at ICAAC

Sep. 29, 1997

New oxazolidinone from P&U described at ICAAC

Sep. 29, 1997

Phosphomannose isomerase as target for antifungal drugs

Sep. 29, 1997

Glaxo Wellcome describes new agents for CMV

Sep. 29, 1997

Schering-Plough and Genome Therapeutics enter antifungal alliance

Sep. 26, 1997

Phase III trial of Neuprex in meningococcemia continues; pilot trial in CF begins

Sep. 25, 1997

LY-303366: efficacy in rabbits with invasive pulmonary aspergillosis

Sep. 25, 1997

Famvir approved by FDA for new indication

Sep. 22, 1997

Vaxar: first launch for new fluoroquinolone

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...